With the increasing prevalence of HIV infection/AIDS and the extending range of care and treatment, the economic implications of the various prevention and control strategies, and of treatment, have become the subject of interest to policy-makers, public health specialists and health economists. This paper presents an overview of the methods used for the economic analysis of AIDS/HIV infection. It proposes an activity-oriented, cost center-based model for the costing of the economic impact of AIDS, using cost figures in Singapore since 1985, when the National AIDS Control Program was started. Priorities for future research are also identified. Asia Pac J Public Health1994;7(3):143-50.
1. CDC.Pneumocystis pneumonia — Los Angeles. MMWR1981; 30: 250–2.
2.
2. CDC.Kaposi's sarcoma and pneumocystis pneumonia among homosexual men — New York City and California. MMWR1981; 30: 305–8.
3.
3. WHO.Acquired Immunodeficiency Syndrome (AIDS) — Data at 1 January 1992. WHO Weekly Epidemiological Record1992; 67: 9–16.
4.
4. WHO. AIDS: Over a million new infections in eight months. WHO Press Release WHO/9. 12 February 1992.
5.
5. Edstrom K. The impact of AIDS on society and development. Paper presented at the Workshop on the Management of National AIDS Prevention and Control Programs.Manila, Philippines, 30 September—2 October 1991.
6.
6. Ministry of Health, Singapore.
7.
7. Gray AM. Economic aspects of AIDS and HIV infection in the UK. Department of Public Health and Policy, UK. PHP Departmental Publication No 2, 1991.
8.
8. Kouri YH, Shepard DS, Borras F., et al. Improving the cost-effectiveness of AIDS health care in San Juan, Puerto Rico. Lancet1991; 337: 1397–9.
9.
9. Castellano AR, Nettleman MD. Cost and benefit of secondary prophylaxis for pneumocystis carinii pneumonia. JAMA1991; 266: 820–4.
10.
10. Schulman KA, Lynn LA, Glick HA, et al. Cost-effectiveness of low-dose Zidovudine therapy for asymptomatic patients with Human Immunodeficiency Virus (HIV) infection. Ann Intern Med1991; 114: 798–802.
11.
11. Freedberg KA. The cost-effectiveness of PCP prophylaxis and the early use of Zidovudine. Highlights of a seminar meeting: Economic Aspects of HIV Management. 6 April 1991, Lausanne, Switzerland.
12.
12. Kaplan RM, Anderson JP, Wu AW, et al. The Quality of Well-being Scale — applications in AIDS, cystic fibrosis and arthritis. Med Care1989(suppl); 27: S27–S43.
13.
13. Kaplan RM. Value for money in management of HIV: health-related quality of life. Highlights of a seminar meeting: Economic Aspects of HIV Management. 6 April 1991, Lausanne, Switzerland.
14.
14. Kambou G, Devarajan S, Over M. A Computable General Equilibrium analysis of the economic impact of the AIDS epidemic in Sub-Saharan Africa. Paper prepared for the Fifth International Conference on AIDS, Montreal, Quebec, Canada.1989.
15.
15. Hardy AM, Rauch K, Echenberg D, et al. The economic impact of first 10, 000 cases of Acquired Immunodeficiency Syndrome in the United States. JAMA1986; 255: 209–11.
16.
16. Scitovsky AA, Rice DP. Estimates of the direct and indirect costs of Acquired Immunodeficiency Syndrome in the United States, 1985, 1986and 1991. Public Health Rep January-February1987; 102: 5–17.
17.
17. Dunlop WD. The economic impact of the disease AIDS: an analysis of the costs of the disease and a proposed study strategy in poor countries. 1987.
18.
18. Scitovsky AA, Over M. AIDS: costs of care in the developed and the developing world. AIDS1988; 2(suppl 1): S71–S81.
19.
19. Drummond M, Davies L. Treating AIDS: the economic issues. Health Policy1988; 10: 1–19.
20.
20. Drummond MF, Davies LM. Topics for economic analysis.In: Drummond MFand Davies LM, editors. AIDS: the challenge for economic analysis. UK: University of Birmingham, 1990.
21.
21. Ministry of Health, Singapore.
22.
22. Lindgren B, Silverberg R. Economic Burden of AIDS. In: Drummond MF and Davies LM, editors, op cit.
23.
23. Chan RKW. AIDS/HIV Infection-The local situation. Presentation at the National Workshop on AIDS.30 November 1991, Singapore.
24.
24. Sisk JE. Trends in the prevention, diagnosis and treatment of HIV and their economic implications. In: and LM Davies, editors. op cit.
25.
25. Drummond MF, Davies LM: Issues and prospects for economic analysis. In: MF Drummond and LM Davies, editors, op. cit.
